Concepedia

Eugene H. Herman

EH

Statistics

Publications

49

Citations

3.5K

H-Index

29

Active since

1978

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Heart Lung and Blood Institute

National Institutes of Health

University of Miami

Eugene H. Herman is an author at United States Food and Drug Administration specializing in pharmacology, medicine, and doxorubicin cardiotoxicity.

Publications per year

1978–2022

49

Publications

49

Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions

Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan et al. · Circulation · 2013 · 614 citations

Medicine, Oncology, Pediatrics +14

Anthracycline Cardiotoxicity: From Bench to Bedside

Luca Gianni, Eugene H. Herman, Steven E. Lipshultz et al. · Journal of Clinical Oncology · 2008 · 453 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin

Eugene H. Herman, Jun Zhang, Steven E. Lipshultz et al. · Journal of Clinical Oncology · 1999 · 209 citations

Medicine, Cardiology, Pathobiology +17

Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.

Eugene H. Herman, Steven E. Lipshultz, Nader Rifai et al. · PubMed · 1998 · 153 citations

Medicine, Pharmacology, Toxicology +17

Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury

Jun Zhang, Alan Knapton, Steven E. Lipshultz et al. · Toxicologic Pathology · 2008 · 126 citations

Pharmacy, Pharmacology, Toxicology +13

1–5 of 49